In TTP patients, this effect is supposed to be mainly mediated by the formation of endothelial-derived ultra-large von Willebrand factor fibers (ULVWFs) and platelet aggregation3,4. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.